Patents Assigned to Biomind Labs Inc
  • ENCAPSULATED MICROPARTICLES AND NANOPARTICLES OF DIMETHYLTRIPTAMINES
    Publication number: 20240408063
    Abstract: The present invention relates to a process of obtaining encapsulated microparticles and/or nanoparticles of DMT/5-MeO-DMT, or pharmaceutically acceptable salts or derivatives thereof and a composition prepared by the process. Pharmaceutical compositions comprising the particles can further include an inhibitor of the Monoamine oxidase (MAOI), and are useful for the personalized treatment of neurological and/or psychiatric disorders, and/or inflammatory disorders.
    Type: Application
    Filed: September 29, 2022
    Publication date: December 12, 2024
    Applicant: Biomind Labs Inc.
    Inventor: Alejandro Carlos ANTALICH RAIBAR
  • ISOTOPICALLY LABELED TRYPTAMINES AND ANALOGS THEREOF
    Publication number: 20230067402
    Abstract: The present invention discloses compounds of formula (I) wherein R1 is H, OH, PO4H2, OCH3, or SCH3; wherein R2 is H or and wherein R3 and R4 are H or CH3; and the compound of formula (I) has one or more of a 15N atom and/or a 13C atom. Also disclosed are methods of making the compounds of formula (I), as well as pharmaceutical compositions containing a compound of formula (I) and DMT or 5-MeO-DMT.
    Type: Application
    Filed: August 12, 2022
    Publication date: March 2, 2023
    Applicant: Biomind Labs Inc
    Inventors: Lucía Fernanda Minini Rivas, Fernando Amaury Ferreira Chiesa, Dráulio Barros de Araújo, Paola Alexandra Díaz Dellavalle